← Back
$TARS All transactions

Tarsus Pharmaceuticals, Inc.

▼ SELL

$ Value

$283K

Shares

4,231

Price

$67

Filed

Mar 19

Insider

Name

Wahl Bryan

Title

General Counsel

CIK

0001841401

Roles

Officer

Transaction Details

Transaction Date

2026-03-19

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

63,959

Footnotes

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Filing Info

Accession No.

0001841401-26-000007

Form Type

4

Issuer CIK

0001819790

Wahl Bryan's History

Date Ticker Type Value
2026-03-19 TARS $283K
2026-03-18 TARS $283K
2026-03-17 TARS $284K
2026-03-15 TARS M
2026-03-15 TARS M $0
2026-03-15 TARS M $0
2026-03-15 TARS M $0
2026-03-15 TARS M $0
2026-03-05 TARS A $0
2026-03-05 TARS A $0

Other Insiders at TARS (90d)

Insider Bought Sold Last
PYOTT DAVID E I 2026-02-18
LINK WILLIAM J PHD $860K 2026-03-16
Farrow Jeffrey S
See Remarks
$440K 2026-03-19
Mottiwala Aziz
Chief Commercial Officer
$893K 2026-03-19
Neervannan Seshadri
Chief Operating Officer
$1.6M 2026-03-20
Azamian Bobak R.
President/CEO and Board Chair
$2.4M 2026-03-19
Whitfield Dianne C.
Chief Human Resources Officer
$839K 2026-03-19
Wahl Bryan
General Counsel
$567K 2026-03-18
Lin Elizabeth Yeu
Chief Medical Officer
$78K 2026-03-19